<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<style type="text/css">
.txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url("0.otf"); }
.f1 { font-family:ff0,serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff2; src: url("2.otf"); }
.f2 { font-family:ff2,serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff4; src: url("4.otf"); }
.f3 { font-family:ff4,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff7; src: url("7.otf"); }
.f4 { font-family:ff7,serif; font-weight:normal; font-style:normal; }
</style>
</head>
<body>
<img style="position:absolute; left:0px; top:0px;" width="595" height="793" src="page9.png"">
<div class="txt" style="position:absolute; left:37px; top:48px;"><span class="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">H. Nadeeshani, J. Li, T. Ying et al.</span></div>
<div class="txt" style="position:absolute; left:413px; top:48px;"><span class="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Journal of Advanced Research 37 (2022) 267–278</span></div>
<div class="txt" style="position:absolute; left:37px; top:67px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">and Drug Administration (FDA), which is yet to be achieved for</span></div>
<div class="txt" style="position:absolute; left:37px; top:78px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">NMN.</span></div>
<div class="txt" style="position:absolute; left:49px; top:88px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Mills et al. [10] reported that </span><span class="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">in vivo </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">long-term administration</span></div>
<div class="txt" style="position:absolute; left:37px; top:99px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">of NMN mitigated age-associated physiological decline, effectively</span></div>
<div class="txt" style="position:absolute; left:37px; top:109px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">without generating noticeable toxicity, deleterious side effects or</span></div>
<div class="txt" style="position:absolute; left:37px; top:120px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">raised mortality. Tsubota [76] reported that the ﬁrst phase I human</span></div>
<div class="txt" style="position:absolute; left:37px; top:130px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">clinical study (UMIN000021309) has been initiated aiming at eval-</span></div>
<div class="txt" style="position:absolute; left:37px; top:141px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">uating the bioavailability, mechanism of action and the safety of</span></div>
<div class="txt" style="position:absolute; left:37px; top:151px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">NMN in the human body. This has been a collaborative study</span></div>
<div class="txt" style="position:absolute; left:37px; top:162px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">between Keio University School of Medicine in Tokyo and Wash-</span></div>
<div class="txt" style="position:absolute; left:37px; top:172px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">ington University School of Medicine in St. Louis. Using ten healthy</span></div>
<div class="txt" style="position:absolute; left:37px; top:182px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">volunteers, the time course of blood NMN concentration and the</span></div>
<div class="txt" style="position:absolute; left:37px; top:193px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">safety of NMN administration were assessed, which was intended</span></div>
<div class="txt" style="position:absolute; left:37px; top:203px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">for developing anti-aging nutraceutical. However, the research</span></div>
<div class="txt" style="position:absolute; left:37px; top:214px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">team has been unsuccessful in detecting NMN in plasma samples.</span></div>
<div class="txt" style="position:absolute; left:49px; top:224px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Irie et al. [77] conducted a non-blinded clinical trial using 10</span></div>
<div class="txt" style="position:absolute; left:37px; top:235px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">healthy men to investigate the safety of oral NMN administration</span></div>
<div class="txt" style="position:absolute; left:37px; top:245px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">and the pharmacokinetics of nicotinamide metabolites at the Keio</span></div>
<div class="txt" style="position:absolute; left:37px; top:256px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">University School Medicine, Japan. They found that single oral</span></div>
<div class="txt" style="position:absolute; left:37px; top:266px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">administration of 100, 250 and 500 mg of NMN doses was well-</span></div>
<div class="txt" style="position:absolute; left:37px; top:277px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">tolerated and safe since it did not cause any observable clinical</span></div>
<div class="txt" style="position:absolute; left:37px; top:287px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">symptoms or changes in body temperature, oxygen saturation,</span></div>
<div class="txt" style="position:absolute; left:37px; top:298px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">blood pressure and heart rate. In addition, signiﬁcant changes in</span></div>
<div class="txt" style="position:absolute; left:37px; top:308px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">ophthalmic, ocular fundus and neurological system parameters</span></div>
<div class="txt" style="position:absolute; left:37px; top:318px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">were not observed after NMN administration. There were no</span></div>
<div class="txt" style="position:absolute; left:37px; top:329px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">changes in the results of laboratory analysis of urine and blood</span></div>
<div class="txt" style="position:absolute; left:37px; top:339px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">as well as sleep quality and score before and after the NMN admin-</span></div>
<div class="txt" style="position:absolute; left:37px; top:350px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">istration. Oral administration of NMN increased serum bilirubin</span></div>
<div class="txt" style="position:absolute; left:37px; top:360px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">contents and decreased blood glucose, chloride and serum crea-</span></div>
<div class="txt" style="position:absolute; left:37px; top:371px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">tinine levels, but within the normal range. NMN administration</span></div>
<div class="txt" style="position:absolute; left:37px; top:381px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">did not increase nicotinamide in blood to the level which causes</span></div>
<div class="txt" style="position:absolute; left:37px; top:392px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">adverse effects associated with high dose of nicotinamide. Since</span></div>
<div class="txt" style="position:absolute; left:37px; top:402px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">the safety of single oral administration of NMN has only been con-</span></div>
<div class="txt" style="position:absolute; left:37px; top:413px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">sidered in this study, further clinical investigations are essential to</span></div>
<div class="txt" style="position:absolute; left:37px; top:423px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">be performed to assess the safety and efﬁcacy of long-term admin-</span></div>
<div class="txt" style="position:absolute; left:37px; top:434px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">istration of NMN. The organs and the tissue NMN levels have not</span></div>
<div class="txt" style="position:absolute; left:37px; top:444px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">been analysed in this study, which should be considered in future</span></div>
<div class="txt" style="position:absolute; left:37px; top:454px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">clinical studies.</span></div>
<div class="txt" style="position:absolute; left:49px; top:465px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">As stated by Hong et al. [15], three more human clinical studies</span></div>
<div class="txt" style="position:absolute; left:37px; top:475px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">are being carried out to evaluate the safety concerns of NMN</span></div>
<div class="txt" style="position:absolute; left:37px; top:486px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">administration. One study is a phase II study (UMIN000030609),</span></div>
<div class="txt" style="position:absolute; left:37px; top:496px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">which has been initiated by the Keio University School of Medicine,</span></div>
<div class="txt" style="position:absolute; left:37px; top:507px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Japan to evaluate the safety of long-term administration of NMN,</span></div>
<div class="txt" style="position:absolute; left:37px; top:517px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">pharmacokinetics and metabolites of NMN, and its effect on glu-</span></div>
<div class="txt" style="position:absolute; left:37px; top:528px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">cose metabolism in healthy adults. Another study is being per-</span></div>
<div class="txt" style="position:absolute; left:37px; top:538px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">formed to assess the effect of long-term intake of NMN on</span></div>
<div class="txt" style="position:absolute; left:37px; top:549px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">different hormones in healthy individuals (UMIN000025739) by</span></div>
<div class="txt" style="position:absolute; left:37px; top:559px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">the Hiroshima University, Institute of Biomedical and Health</span></div>
<div class="txt" style="position:absolute; left:37px; top:570px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Sciences. The third clinical study (UMIN000036321) has been</span></div>
<div class="txt" style="position:absolute; left:37px; top:580px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">designed to assess the consequences of oral administration of</span></div>
<div class="txt" style="position:absolute; left:37px; top:590px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">NMN on the body composition in elderly people at the University</span></div>
<div class="txt" style="position:absolute; left:37px; top:601px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">of Tokyo Hospital. These clinical trials are still ongoing and there</span></div>
<div class="txt" style="position:absolute; left:37px; top:611px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">is no result published yet. Yoshino et al. [23] have also highlighted</span></div>
<div class="txt" style="position:absolute; left:37px; top:622px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">the importance of more comprehensively assessing potential</span></div>
<div class="txt" style="position:absolute; left:37px; top:632px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">adverse effects of NMN by conducting preclinical and clinical stud-</span></div>
<div class="txt" style="position:absolute; left:37px; top:643px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">ies, considering different dietary conditions as well.</span></div>
<div class="txt" style="position:absolute; left:49px; top:653px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">According to Di Stefano et al. [78], inhibitors of NMN synthesis-</span></div>
<div class="txt" style="position:absolute; left:37px; top:664px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">ing enzyme (NAMPT), provided robust functional and morpholog-</span></div>
<div class="txt" style="position:absolute; left:37px; top:674px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">ical protection of injured synapses and axons, regardless of</span></div>
<div class="txt" style="position:absolute; left:37px; top:685px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">reducing NAD. But, exogenous NMN eliminated this protection</span></div>
<div class="txt" style="position:absolute; left:37px; top:695px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">with the accumulation of NMN after nerve injury and NMNAT2</span></div>
<div class="txt" style="position:absolute; left:37px; top:706px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">degradation advanced axon degeneration. They suggested that</span></div>
<div class="txt" style="position:absolute; left:37px; top:716px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">the relationship between the increase of NMN and axon degenera-</span></div>
<div class="txt" style="position:absolute; left:37px; top:726px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">tion could be a long-hypothesised toxic and deleterious factor.</span></div>
<div class="txt" style="position:absolute; left:37px; top:737px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Poljsak and Milisav [79] reported that both NR and NMN, as vita-</span></div>
<div class="txt" style="position:absolute; left:37px; top:746px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">min B</span><span class="f1" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">3 </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">forms and NAD</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+ </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">precursors were not detected to be</span></div>
<div class="txt" style="position:absolute; left:306px; top:67px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">cancerogenic. Radenkovic and Verdin [80] also have stated that</span></div>
<div class="txt" style="position:absolute; left:306px; top:78px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">since no study has reported rigorous side effects and they have</span></div>
<div class="txt" style="position:absolute; left:306px; top:88px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">been in use for many years, therapeutic interventions including</span></div>
<div class="txt" style="position:absolute; left:306px; top:99px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">NMN, NR, vitamin B</span><span class="f1" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">3 </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">and niacin supplementation, which increase</span></div>
<div class="txt" style="position:absolute; left:306px; top:108px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">NAD</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+ </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">levels, are likely to be fairly safe for the human use.</span></div>
<div class="txt" style="position:absolute; left:318px; top:120px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Radenkovic and Verdin [80] further explained that side effects</span></div>
<div class="txt" style="position:absolute; left:306px; top:130px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">of long-term NAD upregulation are complicated to identify and</span></div>
<div class="txt" style="position:absolute; left:306px; top:141px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">quantify, but they still can exist. In addition, it was illustrated that</span></div>
<div class="txt" style="position:absolute; left:306px; top:151px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">prolonged high dose of vitamin B</span><span class="f1" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">3 </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">compounds, including NMN</span></div>
<div class="txt" style="position:absolute; left:306px; top:162px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">may possibly have long-term side effects. According to Rolfe [68],</span></div>
<div class="txt" style="position:absolute; left:306px; top:172px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">NAD upregulation has the possibility to make worse the</span></div>
<div class="txt" style="position:absolute; left:306px; top:182px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">senescence-associated secretory phenotype (SASP) generated by</span></div>
<div class="txt" style="position:absolute; left:306px; top:193px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">senescent cells in aged tissues. A suggested mechanism to cause</span></div>
<div class="txt" style="position:absolute; left:306px; top:202px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">this side effect was the suppression of 5</span><span class="f3" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">0 </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">adenosine</span></div>
<div class="txt" style="position:absolute; left:306px; top:214px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">monophosphate-activated protein kinase and tumor protein p53,</span></div>
<div class="txt" style="position:absolute; left:306px; top:224px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">directing to stimulate nuclear factor kappa B protein transcription</span></div>
<div class="txt" style="position:absolute; left:306px; top:235px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">factor through p38 mitogen-activated protein kinases and raised</span></div>
<div class="txt" style="position:absolute; left:306px; top:245px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">expression of inﬂammatory cytokines. The cellular senescence bur-</span></div>
<div class="txt" style="position:absolute; left:306px; top:256px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">den enlarged with aging, while the produced ASAP was a responsi-</span></div>
<div class="txt" style="position:absolute; left:306px; top:266px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">ble factor for different age-related pathologies [81].</span></div>
<div class="txt" style="position:absolute; left:318px; top:277px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">However, evidences to support these potential side effects of</span></div>
<div class="txt" style="position:absolute; left:306px; top:287px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">long-term NMN usage and NAD upregulation are lacking. In fact,</span></div>
<div class="txt" style="position:absolute; left:306px; top:298px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">the usage of anti-aging interventions is expected to be initiated</span></div>
<div class="txt" style="position:absolute; left:306px; top:308px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">at comparatively younger and healthier age than very old age.</span></div>
<div class="txt" style="position:absolute; left:306px; top:318px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Therefore, identiﬁcation and quantiﬁcation of adverse effects and</span></div>
<div class="txt" style="position:absolute; left:306px; top:329px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">challenges of long-term utilisation of anti-aging health products</span></div>
<div class="txt" style="position:absolute; left:306px; top:339px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">is extremely essential and critical since these anti-aging products</span></div>
<div class="txt" style="position:absolute; left:306px; top:350px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">are apparently used for a long time. According to Yu et al. [82],</span></div>
<div class="txt" style="position:absolute; left:306px; top:360px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">NMN treatment (400 mg/kg) obstructed the exercise-induced ben-</span></div>
<div class="txt" style="position:absolute; left:306px; top:371px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">eﬁts of a mouse model of diet-induced obesity such as reduced</span></div>
<div class="txt" style="position:absolute; left:306px; top:381px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">hepatic triglyceride accumulation, glucose stimulated insulin</span></div>
<div class="txt" style="position:absolute; left:306px; top:392px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">secretion from islets and glucose tolerance. This ﬁnding should</span></div>
<div class="txt" style="position:absolute; left:306px; top:402px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">be further investigated thoroughly since the exercise is one of</span></div>
<div class="txt" style="position:absolute; left:306px; top:413px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">the key components for maintaining health and wellbeing of the</span></div>
<div class="txt" style="position:absolute; left:306px; top:423px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">elderly.</span></div>
<div class="txt" style="position:absolute; left:306px; top:454px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Conclusions</span></div>
<div class="txt" style="position:absolute; left:318px; top:474px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">NMN is a precursor of NAD</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+ </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">and an intermediate of NAD</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+</span></div>
<div class="txt" style="position:absolute; left:306px; top:486px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">biosynthesis, which is achieved through three pathways. NMN is</span></div>
<div class="txt" style="position:absolute; left:306px; top:495px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">an intermediate by-product in two of them. NAD</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+ </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">levels in the</span></div>
<div class="txt" style="position:absolute; left:306px; top:505px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">body are depleted with aging as a result of activities of NAD</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+ </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">con-</span></div>
<div class="txt" style="position:absolute; left:306px; top:516px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">suming enzymes. Depletion of NAD</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+ </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">level is associated with down-</span></div>
<div class="txt" style="position:absolute; left:306px; top:528px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">regulation of energy production in mitochondria, increasing</span></div>
<div class="txt" style="position:absolute; left:306px; top:538px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">oxidative stress, DNA damage, cognitive impairments and inﬂam-</span></div>
<div class="txt" style="position:absolute; left:306px; top:547px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">matory diseases. NMN, as the precursor of NAD</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+</span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">, has been seen</span></div>
<div class="txt" style="position:absolute; left:306px; top:559px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">to likely reverse these age-related complications and slow down</span></div>
<div class="txt" style="position:absolute; left:306px; top:568px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">the rate of aging by enhancing NAD</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+ </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">levels in the body.</span></div>
<div class="txt" style="position:absolute; left:318px; top:580px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Many studies have been done to explore NMN’s anti-aging</span></div>
<div class="txt" style="position:absolute; left:306px; top:591px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">effects in various cells and tissues. Most of the works have been</span></div>
<div class="txt" style="position:absolute; left:306px; top:601px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">done </span><span class="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">in vitro </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">or in animal models. However, published reports</span></div>
<div class="txt" style="position:absolute; left:306px; top:611px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">about NMN’s long-term safety and clinical efﬁcacy of anti-aging</span></div>
<div class="txt" style="position:absolute; left:306px; top:622px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">effects in humans are scarce. From the above review, it can be seen</span></div>
<div class="txt" style="position:absolute; left:306px; top:632px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">that only very few pre-clinical and clinical studies have been con-</span></div>
<div class="txt" style="position:absolute; left:306px; top:643px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">ducted to investigate the safety of long-term administration of</span></div>
<div class="txt" style="position:absolute; left:306px; top:653px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">NMN. A few more human clinical trials are being conducted to</span></div>
<div class="txt" style="position:absolute; left:306px; top:664px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">evaluate the safety concerns of NMN supplementation and the out-</span></div>
<div class="txt" style="position:absolute; left:306px; top:674px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">comes are yet to be available.</span></div>
<div class="txt" style="position:absolute; left:318px; top:685px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">However, many NMN anti-aging health products are already</span></div>
<div class="txt" style="position:absolute; left:306px; top:695px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">available in the market and manufacturers are aggressively mar-</span></div>
<div class="txt" style="position:absolute; left:306px; top:706px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">keting the products using </span><span class="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">in vitro </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">and </span><span class="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">in vivo </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">results from the liter-</span></div>
<div class="txt" style="position:absolute; left:306px; top:716px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">ature. Therefore, the ﬁrst priority should be to establish toxicology,</span></div>
<div class="txt" style="position:absolute; left:306px; top:726px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">pharmacology and safety proﬁles of NMN in humans, including</span></div>
<div class="txt" style="position:absolute; left:306px; top:737px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">healthy and diseased. For NMN’s anti-aging efﬁcacy, the most fea-</span></div>
<div class="txt" style="position:absolute; left:306px; top:747px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">sible route to obtain data will probably through long-term follow-</span></div>
<div class="txt" style="position:absolute; left:291px; top:764px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">275</span></div>
</body>
</html>
